| LG51354-5 | Transitional cells.deep · Urine/Urine sed | 3 |
| LG51355-2 | Free lipid droplets · Urine/Urine sed | 3 |
| LG51356-0 | Hyaline-granular casts · Urine/Urine sed | 3 |
| LG51357-8 | Microorganism casts · Urine/Urine sed | 3 |
| LG51358-6 | Calcium oxalate monohydrate crystals · Urine/Urine sed | 3 |
| LG51360-2 | Atypical crystals · Urine/Urine sed | 3 |
| LG51361-0 | Bacilliform bacteria · Urine/Urine sed | 3 |
| LG51362-8 | Cocci bacteria · Urine/Urine sed | 3 |
| LG51363-6 | Schistosoma haematobium · Urine/Urine sed | 3 |
| LG51364-4 | FluoroquinoloneSusc · Isolate | 2 |
| LG51365-1 | AminoglycosideSusc · Isolate | 2 |
| LG51366-9 | CefcapeneSusc · Isolate | 2 |
| LG51367-7 | CefteramSusc · Isolate | 2 |
| LG51368-5 | PrulifloxacinSusc · Isolate | 2 |
| LG51369-3 | TosufloxacinSusc · Isolate | 2 |
| LG51370-1 | CefquinomeSusc · Isolate | 2 |
| LG51371-9 | RifapentineSusc · Isolate | 2 |
| LG51372-7 | Erythromycin+EthambutolSusc · Isolate | 2 |
| LG51373-5 | AtovaquoneSusc · Isolate | 2 |
| LG51374-3 | Azithromycin+EthambutolSusc · Isolate | 2 |
| LG51375-0 | CefozopranSusc · Isolate | 2 |
| LG51376-8 | Clarithromycin+EthambutolSusc · Isolate | 2 |
| LG51377-6 | FlomoxefSusc · Isolate | 2 |
| LG51378-4 | OptochinSusc · Isolate | 2 |
| LG51379-2 | PanipenemSusc · Isolate | 2 |
| LG51380-0 | ProthionamideSusc · Isolate | 3 |
| LG51381-8 | Acetaminophen-cysteine adduct · SCnc · Pt · ANYBldSerPl | 2 |
| LG51382-6 | Furanylfentanyl · ANYProp · ANYTm · ANYSys · ANYMeth | 2 |
| LG51386-7 | Titin Ab · ACnc · Pt · ANYBldSerPl | 2 |
| LG51387-5 | Squalene · Pt · Ser/Plas · 410.73 g/mole | 2 |
| LG51388-3 | Stigmasterol · Pt · Ser/Plas · 412.702 g/mole | 2 |
| LG51389-1 | 8(9)-Cholestenol · Pt · Ser/Plas | 2 |
| LG51390-9 | Glial fibrillary acidic protein · MCnc · Pt · ANYBldSerPl | 3 |
| LG51391-7 | Ubiquitin carboxyl-terminal hydrolase-L1 · MCnc · Pt · ANYBldSerPl | 3 |
| LG51396-6 | Mycoplasma genitalium rRNA · PrThr · Sys:ANYGU | 3 |
| LG51397-4 | Rifabutin+EthambutolSusc · Isolate | 2 |
| LG51398-2 | Hepatocellular carcinoma risk · Score · Pt · ^Patient | 2 |
| LG51399-0 | Undersea and hyperbaric medicine · ANYTypeOfService · ANYKindOfNote · ANYSetting | 4 |
| LG51400-6 | Nonalcoholic steatohepatitis score · Score · Pt · ANYBldSerPl | 2 |
| LG51401-4 | Alpha-1-Acid glycoprotein · MCnc · Pt · ANYBldSerPl | 2 |
| LG51402-2 | Protein fractions.oligoclonal bands · Num · Pt · ANYBldSerPl | 2 |
| LG51403-0 | Vasopressin^1st specimen post XXX challenge · Pt · Plas | 2 |
| LG51404-8 | Testosterone · Pt · Body fld · 288.431 g/mole | 2 |
| LG51405-5 | Corticotropin^9th specimen post XXX challenge · Pt · Plas | 2 |
| LG51406-3 | Vasopressin^2nd specimen post XXX challenge · Pt · Plas | 2 |
| LG51407-1 | XR · Radius+Ulna · View · Laterality:ANY | 4 |
| LG51408-9 | US · Breast · Guidance for cryoablation · Laterality:ANY | 2 |
| LG51409-7 | MR · Kidney · Guidance for percutaneous biopsy · Laterality:ANY | 2 |
| LG5141-9 | SCL-70 extractable nuclear Ab · PrThr · Pt · ANYBldSerPl | 5 |
| LG51410-5 | Protein.abnormal band · MCnc · Pt · ANYBldSerPl | 2 |